Karen Knudsen: American Cancer Society and ACS CAN applaud Fifth Circuit’s decision to protect access to preventive services
Karen Knudsen shared a post by American Cancer Society Cancer Action Network on LinkedIn:
“The evidence is clear: prevention, screening, and early detection are critical to better cancer outcomes. Since the enactment of the Affordable Care Act, preventive and regular care rates have increased, saving millions of lives from cancer and other chronic diseases.
American Cancer Society and American Cancer Society Cancer Action Network (ACS CAN) applaud today’s decision by the Fifth Circuit to protect access to these preventive services, noting amicus briefs that provide scientific data on their importance. This is critical to ending cancer as we know it, for everyone.”
Quoting American Cancer Society Cancer Action Network’s post:
“ACS CAN and over a dozen Public Health organizations applaud today’s decision by the U.S. Court of Appeals for the Fifth Circuit to uphold the critical patient protections in the Affordable Care Act for the vast majority of individuals covered.
This decision by the Fifth Circuit protects continued, broad access to cost-free preventive services for more than 150 million eligible individuals, and specifically notes amicus briefs such as the one filed by our groups, providing scientific data on the importance of Preventive Services.
We know coverage of recommended preventive services without cost-sharing has saved millions of lives from chronic diseases like cancer.
Read the full statement.”
Source: Karen Knudsen/LinkedIn and American Cancer Society Cancer Action Network/LinkedIn
Karen E. Knudsen is the CEO of the American Cancer Society (ACS) and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN). Prior to joining ACS, Dr. Knudsen served as executive vice president of Oncology Services and enterprise director for Sidney Kimmel Cancer Center at Jefferson Health.
She also served as president for the Association of American Cancer Institutes (AACI), representing the 102 leading cancer centers in North America, and on the board of directors of the American Association for Cancer Research (AACR). Dr. Knudsen currently holds leadership roles with some of the most important cancer entities in the United States.
She serves on the board of advisors for the National Cancer Institute and on 12 external advisory boards for NCI-designated cancer centers. She is an active member of several committees with the American Society for Clinical Oncology (ASCO), in addition to serving on other academic and for-profit advisory boards.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023